A preliminary retrospective analysis of weekly topotecan in recurrent smallcell lung cancer.

被引：0
|
作者：
Kasturi, VK
Eckardt, JR
Greco, FA
机构：
[1] Dartmouth Hitchcock Keene Kingsbury Ctr Canc Care, Keene, NH USA
[2] St Johns Mercy Med Ctr, St Louis, MO 63141 USA
[3] Sarah Cannon Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7359
引用
收藏
页码：705S / 705S
页数：1
相关论文
共 50 条
  • [41] Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study
    Syrios, John
    Kouroussis, Charalambos
    Kotsakis, Athanasios
    Kentepozidis, Nikolaos
    Kontopodis, Emmanouil
    Kalbakis, Kostas
    Vardakis, Nikolaos
    Hatzidaki, Dora
    Polyzos, Aris
    Georgoulias, Vassilis
    MINERVA GINECOLOGICA, 2019, 71 (03): : 182 - 190
  • [42] Prognostic value of PET/CT in lung cancer. Retrospective analysis of 47 patients
    Ladron de Guevara, David
    Fuentes, Anibal
    Farina, Cyro
    Corral, Camilo
    Pefaur, Raul
    REVISTA MEDICA DE CHILE, 2013, 141 (01) : 41 - 48
  • [43] Tazemetostat in combination with topotecan and pembrolizumab in patients with recurrent small cell lung cancer
    Desai, Parth Anil
    Takahashi, Nobuyuki
    Lissa, Delphine
    Nichols, Samantha
    Sciuto, Linda
    Abel, Melissa Lauren
    Schroeder, Brett
    Schultz, Christopher
    Steinberg, Seth M.
    Pinkiert, Danielle
    Vilimas, Rasa J.
    Thomas, Anish
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Successful treatment with weekly paclitaxel in a patient with recurrent endometrial cancer. A case report
    Chang, SJ
    Chen, TC
    Wang, TY
    Hsu, CY
    Chen, HS
    Yang, YC
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2003, 24 (05) : 377 - 378
  • [45] Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer
    H Gelderblom
    A Sparreboom
    M J A de Jonge
    W J Loos
    E Wilms
    M A Mantel
    B Hennis
    I Camlett
    J Verweij
    M E L van der Burg
    British Journal of Cancer, 2001, 85 : 1124 - 1129
  • [46] Completion pneumonectomy for recurrent or second primary lung cancer.
    Muraoka M.
    Oka T.
    Takahashi T.
    Akamine S.
    Morinaga M.
    Nagayasu T.
    Tagawa Y.
    Ayabe H.
    The Japanese Journal of Thoracic and Cardiovascular Surgery, 2001, 49 (7): : 407 - 413
  • [47] Weekly topotecan as second- or third-line treatment in patients with recurrent or metastatic cervical cancer
    Coronel, Jaime
    Cetina, Lucely
    Candelaria, Myrna
    Gonzalez-Fierro, Aurora
    Arias, Daimy
    Cantu, David
    Duenas-Gonzalez, Alfonso
    MEDICAL ONCOLOGY, 2009, 26 (02) : 210 - 214
  • [48] A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer
    S. Agelaki
    E. Kontopodis
    A. Kotsakis
    V. Chandrinos
    I. Bompolaki
    Ζ. Zafeiriou
    E. Papadimitraki
    D. Stoltidis
    K. Kalbakis
    V. Georgoulias
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 45 - 51
  • [49] A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer
    Agelaki, S.
    Kontopodis, E.
    Kotsakis, A.
    Chandrinos, V.
    Bompolaki, I.
    Zafeiriou, Z.
    Papadimitraki, E.
    Stoltidis, D.
    Kalbakis, K.
    Georgoulias, V.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 45 - 51
  • [50] A retrospective review of nutritional status and immunotherapy in lung cancer.
    Lee, Chung-Shien
    Sin, Rebecca
    Fishbein, Joanna Stein
    Devoe, Craig E.
    Zhu, Xinhua
    Lee, Mee-Young
    Seetharamu, Nagashree
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345